Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

RELEASE DATE
19-Sep-2018
REGION
North America
Research Code: MC9B-01-00-00-00
SKU: HC03081-NA-MR_22316
$4,950.00
In stock
SKU
HC03081-NA-MR_22316
$4,950.00
Links

Pay by invoice

ENQUIRE NOW

Description

The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global biologics Contract Development and Manufacturing Organization (CDMO) landscape with an emphasis on the key trends and growth opportunities across the global biologics outsourcing market. It also highlights the shifting focus and investments of pharma/biotech participants toward BioCDMOs for innovative biologics discovery, development, and manufacturing.

With the changing market landscape, BioCDMOs are shifting toward providing value-added services by establishing themselves as a one-stop-shop for their pharma clients. These companies are adopting advanced manufacturing technologies such as single-use/disposable bioreactors, continuous, POD manufacturing, and so on with the integration of IT-based solutions implementing the Industrial Internet of Things (IIoT) by means of strategic collaborations and partnerships. Larger participants are resorting to Mergers and Acquisitions (M&As) in order to gain specific therapeutic and technical expertise from smaller, niche BioCDMOs. While the US and Europe are key markets, the outsourcing trend is slowly shifting toward APAC with several new entrants providing cost-effective drug development services.

Research Scope

The study aims at identifying some key growth opportunities such as biosimilars co-development, designer cell lines, bioanalytical development and services, and so on that are set to drive the market over the next 5 years. It provides revenue forecasts of the global BioCDMO market as well as a breakdown by type of cell culture (mammalian versus microbial) and service type (drug substance verus drug product). The study highlights some of the key market drivers and restraints that will affect the overall growth of the market. Additionally, it provides an insight into leading disruptive technology trends such as improvements in upstream and downstream technologies, advances in lyophilisation, and increased application of Process Analytical Technologies (PAT) that are shaping the future of the BioCDMO industry. The study also highlights some emerging business models such as expanding services of CMOs into early stage of drugs, emergence of virtual biotech, out-licensing, and risk sharing between pharma and CMOs that are disrupting traditional business models.


Key Issues Addressed

  • Is the biologic contract manufacturing market growing, how long will it continue to grow and at what rate?
  • What are the fastest growing segments of the biologics contract development and manufacturing market?
  • What growth opportunities exist in the biologics contract development and manufacturing industry?
  • What are the key drivers and restraints affecting the growth of CDMOs?
  • What are the key challenges that CDMOs are likely to face in the near and long-term future? How can CDMOs strategize to overcome these hurdles?
  • In what ways is the biologics contract manufacturing industry likely to change to meet industry trends and dynamics?
  • Which are the game-changing companies and what are the disruptive technologies and business models? How do CDMOs position their assets with pharma companies?

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Key Findings

Scope and Segmentation

Market Engineering Measurements

CEO’s Perspective

8 Big Market Themes for BioCDMO Market

Defining Trends in the Biologics CDMO Market

Executive Summary—3 Big Predictions

Market Overview

Definitions

Pharmaceutical Outsourcing Value Chain

Market Segmentation

Global Market Perspective

Macro Trends—Biologics Development and Manufacturing

Technology Trends—Biologics Development and Manufacturing

Emerging CDMO Business Model

Changing Business Model—Rise in Virtual Pharma

Virtual Pharma—Change Makers in the Pharma and Biotech Outsourcing Ecosystem

Virtual Biotech Companies Enabled by Outsourcing

Game-changing BioCDMO Companies

New Market Opportunities

Snapshot of Competitive Landscape

Competitive Playbook—Market Share Analysis

Market Drivers

Market Restraints

Entry Barriers of Biologics CDMO Markets

Global CDMO Market—Key Trends

Disruptive Technology Trends Across the BioCDMO Market

Benefits of Disposable Over Stainless Steel Bioreactors

Comparative Analysis of Single-use/Disposable and Traditional Large-capacity Stainless Steel Bioreactors

Comparative Analysis of Perfusion and Batch Manufacturing

CDMO by Technology

Comparative Analysis of Mammalian Versus Microbial Cell Culturing

Market Engineering Measurements

Revenue Forecast

CDMO Outsourcing Potential

Outsourcing Trends and Rationale

Higher Outsourcing Penetration

Segment Analysis—Forecast and Trends

Revenue Forecast by Service Type

Percent Revenue Forecast by Service Type

Revenue Forecast by Cell Culture Type

Growth Opportunities and Companies to Action

Transformation in Industry Ecosystem

5 Major Growth Opportunities

Growth Opportunity 1—IIoT in Manufacturing

Growth Opportunity 2—Designer Cell Lines

Growth Opportunity 3—Biosimilar Co-development

Growth Opportunity 4—Single-Use/Disposable Manufacturing

Growth Opportunity 5—Bioanalytical Development & Services

Strategic Imperatives for Success and Growth

Key Characteristics Influencing CDMO Selection

Stated Versus Unstated Importance of CDMO Selection Factors

Stated Versus Unstated Importance of CDMO Selection Factors Discussion

The Last Word—3 Big Predictions

Legal Disclaimer

Market Engineering Methodology

List of Vendors Included in this Research

List of Exhibits

List of Figures
  • 1. Total BioCDMO Market: Game-changing Strategies, Global, 2017
  • 2. Total BioCDMO Market: Roles of CDMOs in the Drug Development Process, Global, 2017
  • 3. Total BioCDMO Market: Key Market Drivers, Global, 2018–2022
  • 4. Total BioCDMO Market: Key Market Restraints, Global, 2018–2022
  • 5. Total BioCDMO Market: Disruptive Technology Trends, Global, 2017
  • 6. Total BioCDMO Market: Market Engineering Measurements, Global, 2017
List of Charts
  • 1. Total BioCDMO Market: Market Engineering Measurements, Global, 2017
  • 2. Total BioCDMO Market: Market Segmentation, Global, 2017
  • 3. Total BioCDMO Market: Emerging Business Models, Global, 2017
  • 4. Total BioCDMO Market: Market Share Analysis, Global, 2017
  • 5. Total BioCDMO Market: Benefits of Disposable/Single Use Bioreactors, Global, 2017
  • 6. Total BioCDMO Market: Revenue Forecast, Global, 2013–2022
  • 7. Total BioCDMO Market: Biologics Manufacturing Outsourcing Landscape, Global, 2015, 2020, and 2025
  • 8. Biologics Manufacturing Market Landscape, 2015
  • 9. Biologics Manufacturing Market Landscape, 2020
  • 10. Biologics Manufacturing Market Landscape, 2025
  • 11. Total BioCDMO Market: Revenue Forecast by Service Type, Global, 2013–2022
  • 12. Total BioCDMO Market: Percent Revenue Forecast by Service Type, Global, 2013–2022
  • 13. Total BioCDMO Market: Percent Revenue Breakdown by Service Type, Global, 2017
  • 14. Total Biologics CDMO Market: Revenue Forecast by Cell Culture Type, Global, 2013–2022
  • 15. Total BioCDMO Market: Percent Revenue Forecast by Cell Culture Type, Global, 2013–2022
  • 16. Total BioCDMO Market: Percent Revenue Breakdown by Cell Culture Type, Global, 2017
  • 17. Total BioCDMO Market: Stated Versus Unstated Importance of CDMO Selection, Global, 2017
Related Research

Growth Insights—Real World Evidence Analytics Solutions Market

Release Date: 24-Apr-18
Region: North America

Global Biologics Market—Companies-to-Action

Release Date: 20-Nov-17
Region: North America

East African Pharmaceutical Market, Forecast to 2021

Release Date: 27-Sep-17
Region: Africa

Global CRO Market, Forecast to 2021

Release Date: 19-Apr-17
Region: Asia Pacific

Biomarkers Enabling Diabetes and Obesity Management

Release Date: 02-Mar-17
Region: Global

2016 Indonesia Transformational Health Insights

Release Date: 31-May-2016
Region: Asia Pacific

Pharmaceutical Market Access Strategy for Ethiopia

Release Date: 27-May-2016
Region: Africa

Vital Signs The Analyst's Perspective - April 2016 Issue

Release Date: 24-May-2016
Region: Global
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global biologics Contract Development and Manufacturing Organization (CDMO) landscape with an emphasis on the key trends and growth opportunities across the global biologics outsourcing market. It also highlights the shifting focus and investments of pharma/biotech participants toward BioCDMOs for innovative biologics discovery, development, and manufacturing. With the changing market landscape, BioCDMOs are shifting toward providing value-added services by establishing themselves as a one-stop-shop for their pharma clients. These companies are adopting advanced manufacturing technologies such as single-use/disposable bioreactors, continuous, POD manufacturing, and so on with the integration of IT-based solutions implementing the Industrial Internet of Things (IIoT) by means of strategic collaborations and partnerships. Larger participants are resorting to Mergers and Acquisitions (M&As) in order to gain specific therapeutic and technical expertise from smaller, niche BioCDMOs. While the US and Europe are key markets, the outsourcing trend is slowly shifting toward APAC with several new entrants providing cost-effective drug development services.--BEGIN PROMO--

Research Scope

The study aims at identifying some key growth opportunities such as biosimilars co-development, designer cell lines, bioanalytical development and services, and so on that are set to drive the market over the next 5 years. It provides revenue forecasts of the global BioCDMO market as well as a breakdown by type of cell culture (mammalian versus microbial) and service type (drug substance verus drug product). The study highlights so

More Information
No Index No
Podcast No
Table of Contents | Executive Summary~ || Key Findings~ || Scope and Segmentation~ || Market Engineering Measurements~ || CEO’s Perspective~ || 8 Big Market Themes for BioCDMO Market~ || Defining Trends in the Biologics CDMO Market~ || Executive Summary—3 Big Predictions~ | Market Overview~ || Market Overview~ || Definitions~ || Pharmaceutical Outsourcing Value Chain~ || Market Segmentation~ || Global Market Perspective~ || Macro Trends—Biologics Development and Manufacturing~ || Technology Trends—Biologics Development and Manufacturing~ || Emerging CDMO Business Model~ || Changing Business Model—Rise in Virtual Pharma~ || Virtual Pharma—Change Makers in the Pharma and Biotech Outsourcing Ecosystem~ || Virtual Biotech Companies Enabled by Outsourcing~ | Competitive Playbook~ || Game-changing BioCDMO Companies~ || New Market Opportunities~ || Snapshot of Competitive Landscape~ || Competitive Playbook—Market Share Analysis~ | Drivers, Restraints and Trends—Total BioCDMO Market~ || Market Drivers~ || Market Restraints~ || Entry Barriers of Biologics CDMO Markets~ || Global CDMO Market—Key Trends~ || Disruptive Technology Trends Across the BioCDMO Market~ || Benefits of Disposable Over Stainless Steel Bioreactors~ || Comparative Analysis of Single-use/Disposable and Traditional Large-capacity Stainless Steel Bioreactors~ || Comparative Analysis of Perfusion and Batch Manufacturing~ || CDMO by Technology~ || Comparative Analysis of Mammalian Versus Microbial Cell Culturing~ | Forecast and Trends—Total BioCDMO Market~ || Market Engineering Measurements~ || Revenue Forecast~ || CDMO Outsourcing Potential~ || Outsourcing Trends and Rationale~ || Higher Outsourcing Penetration~ || Segment Analysis—Forecast and Trends~ || Revenue Forecast by Service Type~ || Percent Revenue Forecast by Service Type~ || Revenue Forecast by Cell Culture Type~ | Percent Revenue Forecast by Cell Culture Type~ || Growth Opportunities and Companies to Action~ || Transformation in Industry Ecosystem~ || 5 Major Growth Opportunities~ || Growth Opportunity 1—IIoT in Manufacturing~ || Growth Opportunity 2—Designer Cell Lines~ || Growth Opportunity 3—Biosimilar Co-development~ || Growth Opportunity 4—Single-Use/Disposable Manufacturing~ || Growth Opportunity 5—Bioanalytical Development & Services~ || Strategic Imperatives for Success and Growth~ | Customer and End-user Analysis~ || Key Characteristics Influencing CDMO Selection~ || Stated Versus Unstated Importance of CDMO Selection Factors~ || Stated Versus Unstated Importance of CDMO Selection Factors Discussion~ | The Last Word~ || The Last Word—3 Big Predictions~ || Legal Disclaimer~ | Appendix~ || Market Engineering Methodology~ || List of Vendors Included in this Research~ || List of Exhibits~
List of Charts and Figures 1. Total BioCDMO Market: Game-changing Strategies, Global, 2017~ 2. Total BioCDMO Market: Roles of CDMOs in the Drug Development Process, Global, 2017~ 3. Total BioCDMO Market: Key Market Drivers, Global, 2018–2022~ 4. Total BioCDMO Market: Key Market Restraints, Global, 2018–2022~ 5. Total BioCDMO Market: Disruptive Technology Trends, Global, 2017~ 6. Total BioCDMO Market: Market Engineering Measurements, Global, 2017~| 1. Total BioCDMO Market: Market Engineering Measurements, Global, 2017~ 2. Total BioCDMO Market: Market Segmentation, Global, 2017~ 3. Total BioCDMO Market: Emerging Business Models, Global, 2017~ 4. Total BioCDMO Market: Market Share Analysis, Global, 2017~ 5. Total BioCDMO Market: Benefits of Disposable/Single Use Bioreactors, Global, 2017 ~ 6. Total BioCDMO Market: Revenue Forecast, Global, 2013–2022~ 7. Total BioCDMO Market: Biologics Manufacturing Outsourcing Landscape, Global, 2015, 2020, and 2025~ 8. Biologics Manufacturing Market Landscape, 2015~ 9. Biologics Manufacturing Market Landscape, 2020~ 10. Biologics Manufacturing Market Landscape, 2025~ 11. Total BioCDMO Market: Revenue Forecast by Service Type, Global, 2013–2022~ 12. Total BioCDMO Market: Percent Revenue Forecast by Service Type, Global, 2013–2022~ 13. Total BioCDMO Market: Percent Revenue Breakdown by Service Type, Global, 2017~ 14. Total Biologics CDMO Market: Revenue Forecast by Cell Culture Type, Global, 2013–2022~ 15. Total BioCDMO Market: Percent Revenue Forecast by Cell Culture Type, Global, 2013–2022~ 16. Total BioCDMO Market: Percent Revenue Breakdown by Cell Culture Type, Global, 2017~ 17. Total BioCDMO Market: Stated Versus Unstated Importance of CDMO Selection, Global, 2017~
Author Aarti Chitale
Industries Healthcare
WIP Number MC9B-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9571-B1,99C1-B1,9568-B1,9611-B1